Month: September 2015

About WBL of the U.S. Healthcare Industry Foundation Summit

Based in Brussels, Belgium, as executive vice president and general counsel of biopharmaceutical company UCB, Anna Richo has more than two decades of experience in the biotech and pharmaceutical industries. A recognized industry speaker, Anna Richo is a member of several professional organizations, including the Women Business Leaders (WBL) of the U.S. Healthcare Industry Foundation.

With over 3,000 members in senior executive positions, the WBL of the U.S. Healthcare Industry Foundation was established in 2001 to help its members connect and promote their role in the industry. Comprised of leaders from life sciences companies, insurance providers, hospitals, and a variety of other health-care companies, the foundation offers free and dues-paying membership options depending on how intended member involvement.

Throughout the year, the foundation hosts a number of regional events and webinars, some of which qualify for education credits for the American College of Healthcare Executives. Its largest event, the annual three-day WBL Summit, is designed to provide a place for about 150 members to network and learn about trends and challenges in the industry. Attendance to the Summit is limited to preserve a close-knit atmosphere that encourages networking without being overwhelming. With representatives from across the country, it also gives a complete picture of the industry for members, their customers, and their business partners. Summit speakers are selected based on their relevancy to attendees and are encouraged to focus on executive skill-building to help propel the industry forward.

The next summit is scheduled for March 16-18, 2016. Slated to take place on Amelia Island, Florida, the summit is themed Innovative Leadership and will cover such topics as What Makes a Great Leader? and Are You Driving Change or Is It Driving You?

Advertisements

UCB Societal Responsibility Fund Helps People with Epilepsy

As the executive vice president and general counsel for UCB in Brussels, Belgium, Anna Richo focuses on the company’s intellectual property, legal, and corporate compliance departments. Anna Richo utilizes more than 25 years of experience in the pharmaceutical industry to perform her work with the international biopharmaceutical company.

Dedicated to improving the quality of life for people around the world, UCB develops cutting-edge medications and maintains a corporate social responsibility program, which includes the UCB Societal Responsibility Fund. UCB founded the Fund in partnership with the King Baudouin Foundation, a well-known nonprofit organization in Belgium, to improve neurological care and quality of life for people with epilepsy and limited financial resources. By supporting a variety of initiatives worldwide, the Fund helps to grow awareness about epilepsy, improve diagnostic capabilities, promote acceptance for people with the disease, and increase health workers’ understanding of epilepsy.

The Fund awards grants to established organizations and primarily concentrates on two projects, Project HOPE in China – Rainbow Bridge and the Brothers of Charity in Rwanda and the Democratic Republic of Congo. Both projects strive to train neurologists and decrease social stigmas against people with epilepsy.